| Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer S Artale, A Sartore Bianchi, SM Veronese, V Gambi, CS Sarnataro, ... Journal of Clinical Oncology 26 (25), 4217-4219, 2008 | 301 | 2008 |
| Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic … A Sartore-Bianchi, K Bencardino, F Di Nicolantonio, F Pozzi, C Funaioli, ... Targeted oncology 5, 19-28, 2010 | 35 | 2010 |
| The quest for improving treatment of cancer of unknown primary (CUP) through molecularly-driven treatments: a systematic review R Lombardo, F Tosi, A Nocerino, K Bencardino, V Gambi, R Ricotta, ... Frontiers in Oncology 10, 533, 2020 | 25 | 2020 |
| Pooled analysis of clinical outcome of patients with chemorefractory metastatic colorectal cancer treated within phase I/II clinical studies based on individual biomarkers of … A Sartore-Bianchi, A Amatu, E Bonazzina, S Stabile, L Giannetta, G Cerea, ... Targeted Oncology 12, 525-533, 2017 | 16 | 2017 |
| Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: Results from the Cancer Pain Outcome Research (CPOR) Study Group G Apolone, O Corli, E Negri, S Mangano, M Montanari, MT Greco, ... The Clinical journal of pain 25 (8), 671-682, 2009 | 15 | 2009 |
| Linitis plastica of the rectum as a clinical presentation of metastatic lobular carcinoma of the breast F Venturini, V Gambi, S Di Lernia, A Vanzulli, M Bramerio, K Bencardino, ... Journal of clinical oncology: official journal of the American Society of …, 2016 | 11 | 2016 |
| Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in … A Sartore-Bianchi, K Bencardino, F Nicolantonio, F Pozzi, C Funaioli, ... Targeted Oncology 7 (4), 267, 2012 | | 2012 |
| Axillary node dissection and sentinel LN: a monoinstitutional experience C Fasola, V Filipazzi, V Gambi, E Piazza, E Damiani, L Isabella, S Ferrario, ... ANNALS OF ONCOLOGY 18, 50-50, 2007 | | 2007 |
| The role of brain natriuretic peptide (BNP) in the management of chemotherapy-induced cardiotoxicity V Filipazzi, V Gambi, C Fasola, A Gambaro, N Tosca, LD Vecchia, ... EUROPEAN JOURNAL OF ONCOLOGY 12 (2), 93-99, 2007 | | 2007 |
| Ruolo del brain natriuretic peptide (BNP) nella gestione della cardiotossicità da farmaci antiblastici The rôle of brain natriuretic peptide (BNP) in the management of … V Filipazzi, V Gambi, C Fasola, A Gambaro, N Tosca, L Dalla Vecchia, ... Eur. J. Oncol 12 (2), 00-00, 2007 | | 2007 |
| Use of Nt-proBNP as a marker of cardio-toxicity during antiblastic chemotherapy E Piazza, E Schiavello, V Gambi, C Fasola, S Piva, MT Cattaneo, ... ANNALS OF ONCOLOGY 16, 64-64, 2005 | | 2005 |
